Showing results (181-190 of 282) with videos related to

Sort By:
Pageof 29
Clinical and Experimental Rheumatology|May 21, 2010
Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitisE Martín-Mola, J Sieper, M Leirisalo-Repo, et al.
Scandinavian Journal of Rheumatology|April 17, 2008
Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progressionM Hakala, J Risteli, S Aman, et al.
Scandinavian Journal of Rheumatology|March 11, 2009
Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritisK Puolakka, H Kautiainen, T Mottonen, et al.
Scandinavian Journal of Rheumatology|June 23, 2025
Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo studyT Sandström, O Kaipiainen-Seppänen, M Mali, et al.
Nature Communications|June 22, 2017
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritisP Savola, T Kelkka, H L Rajala, et al.
Arthritis Research & Therapy|November 21, 2022
The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritisJ Parantainen, G Barreto, R Koivuniemi, et al.
Clinical and Experimental Rheumatology|December 15, 2007
Serum IL-1beta levels are associated with the presence of erosions in recent onset rheumatoid arthritisK K Eklund, M Leirisalo-Repo, P Ranta, et al.
Annals of the Rheumatic Diseases|November 18, 2005
Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trialK Puolakka, H Kautiainen, M Pekurinen, et al.
The Journal of Rheumatology|November 1, 1996
Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?A Kotaniemi, H Piirainen, L Paimela, et al.
Annals of the Rheumatic Diseases|December 21, 2004
Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up studyK Puolakka, H Kautiainen, T Möttönen, et al.
Pageof 29